“The OptiMSM product appeared to provide a protective effect against nasal obstruction following standardized allergenic challenge at multiple dose levels,” said Dr. Jay Udani, CEO of Medicus Research. “The results, as measured both by Peak Nasal Inspiratory Flow and Visual Analog Scale symptom scores, showed that sub-chronic consumption of a dose as low as three grams each day for fourteen days was effective in providing this potentially protective occurrence.”
OptiMSM, a GRAS-approved MSM from Bergstrom Nutrition, is the result of a proprietary four-stage distillation process that provides purity, quality and consistency.
“This new data is exciting because it suggests OptiMSM may help modulate a healthy immune response in individuals subjected to environmental allergens. It also supports prior data by Barrager et al. (2002) suggesting MSM may help mitigate symptoms of seasonal allergic rhinitis,” said Rod Benjamin, director of technical development for Bergstrom Nutrition. “The results from these two human studies strongly suggest that MSM has potential to support healthy immune response to environmental allergens and that MSM should be studied further for potential uses in mitigating over active allergic response.”
Tim Hammond, VP of Sales & Marketing for Bergstrom Nutrition said added, “This study represents another example of Bergstrom Nutrition’s commitment to research and new applications for MSM. Additional studies extend MSM’s joint support benefits to include even more benefits for skin care, exercise recovery, sports nutrition, support for healthy aging as well as immune response.”
The full research manuscript is currently being drafted and will be published approximately in March.
For more information: www.bergstromnutrition.com